Cytoplasmic PARP-1 is associated with sustained activation of Src-mediated survival signaling, whereas PARP-1 knockdown inhibits Src in pancreatic cancer cell lines [81] (Figure 3B). This evidence concerns the gene SRC and pancreatic neoplasm.